Macleods Pharmaceuticals Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is LINAGLIPTIN, with a corresponding US DMF Number 32498.
Remarkably, this DMF maintains an Active status since its submission on April 05, 2018, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of May 24, 2018, and payment made on April 20, 2018, indicating their dedication to facilitating drug approvals, Categorized as Type II